132 related articles for article (PubMed ID: 21204761)
1. Human sodium iodide symporter added to multidrug resistance 1 small hairpin RNA in a single gene construct enhances the therapeutic effects of radioiodine in a nude mouse model of multidrug resistant colon cancer.
Jeon YH; Ahn SJ; Lee YJ; Lee YL; Lee SW; Park SY; Kim IS; Ahn BC; Ha JH; Lee J
Cancer Biother Radiopharm; 2010 Dec; 25(6):671-9. PubMed ID: 21204761
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy and noninvasive imaging with a dual therapeutic vector expressing MDR1 short hairpin RNA and a sodium iodide symporter.
Park SY; Kwak W; Thapa N; Jung MY; Nam JO; So IS; Kim SY; Yoo J; Lee J; Kim IS
J Nucl Med; 2008 Sep; 49(9):1480-8. PubMed ID: 18703598
[TBL] [Abstract][Full Text] [Related]
3. In vivo long-term imaging and radioiodine therapy by sodium-iodide symporter gene expression using a lentiviral system containing ubiquitin C promoter.
Kim HJ; Jeon YH; Kang JH; Lee YJ; Kim KI; Chung HK; Jeong JM; Lee DS; Lee MC; Chung JK
Cancer Biol Ther; 2007 Jul; 6(7):1130-5. PubMed ID: 17611400
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy.
Kang JH; Chung JK; Lee YJ; Shin JH; Jeong JM; Lee DS; Lee MC
J Nucl Med; 2004 Sep; 45(9):1571-6. PubMed ID: 15347726
[TBL] [Abstract][Full Text] [Related]
5. Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors.
Gan HZ; Zhang GZ; Zhao JS; Zhang FC; Bu LS; Yang SJ; Piao SL; Du ZW; Gao S; Zheng DM
Chin Med J (Engl); 2005 Jun; 118(11):893-902. PubMed ID: 15978189
[TBL] [Abstract][Full Text] [Related]
6. In vivo RNA interference-mediated ablation of MDR1 P-glycoprotein.
Pichler A; Zelcer N; Prior JL; Kuil AJ; Piwnica-Worms D
Clin Cancer Res; 2005 Jun; 11(12):4487-94. PubMed ID: 15958634
[TBL] [Abstract][Full Text] [Related]
7. Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer.
Scholz IV; Cengic N; Baker CH; Harrington KJ; Maletz K; Bergert ER; Vile R; Göke B; Morris JC; Spitzweg C
Gene Ther; 2005 Feb; 12(3):272-80. PubMed ID: 15510175
[TBL] [Abstract][Full Text] [Related]
8. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter.
Petrich T; Helmeke HJ; Meyer GJ; Knapp WH; Pötter E
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):842-54. PubMed ID: 12111124
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin enhances the expression of transgene under control of the CMV promoter in anaplastic thyroid carcinoma cells.
Kim KI; Kang JH; Chung JK; Lee YJ; Jeong JM; Lee DS; Lee MC
J Nucl Med; 2007 Sep; 48(9):1553-61. PubMed ID: 17704247
[TBL] [Abstract][Full Text] [Related]
10. Reversing the silencing of reporter sodium/iodide symporter transgene for stem cell tracking.
Kim YH; Lee DS; Kang JH; Lee YJ; Chung JK; Roh JK; Kim SU; Lee MC
J Nucl Med; 2005 Feb; 46(2):305-11. PubMed ID: 15695791
[TBL] [Abstract][Full Text] [Related]
11. [Reversal of multidrug resistance by MDR1 shRNA expression vector in human leukemia K562/A02 cells].
Xiao XB; Xie ZX; Qin Q
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):422-5. PubMed ID: 17152486
[TBL] [Abstract][Full Text] [Related]
12. AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma.
Ma XJ; Huang R; Kuang AR
Cancer Invest; 2009 Jul; 27(6):673-81. PubMed ID: 19241193
[TBL] [Abstract][Full Text] [Related]
13. Enhanced antitumor effects by combination gene therapy using MDR1 gene shRNA and HSV1-tk in a xenograft mouse model.
Lee SW; Lee YL; Lee YJ; Park SY; Kim IS; Choi TH; Ha JH; Ahn BC; Lee J
Cancer Lett; 2010 May; 291(1):83-9. PubMed ID: 19896764
[TBL] [Abstract][Full Text] [Related]
14. Tumor-targeted radionuclide imaging and therapy based on human sodium iodide symporter gene driven by a modified telomerase reverse transcriptase promoter.
Kim SH; Chung HK; Kang JH; Kim KI; Jeon YH; Jin YN; Yun CO; Chung JK
Hum Gene Ther; 2008 Sep; 19(9):951-7. PubMed ID: 18810799
[TBL] [Abstract][Full Text] [Related]
15. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
[TBL] [Abstract][Full Text] [Related]
16. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo tracer characteristics of an established multidrug-resistant human colon cancer cell line.
Lorke DE; Krüger M; Buchert R; Bohuslavizki KH; Clausen M; Schumacher U
J Nucl Med; 2001 Apr; 42(4):646-54. PubMed ID: 11337555
[TBL] [Abstract][Full Text] [Related]
18. Expression of the human sodium/iodide symporter (hNIS) in xenotransplanted human thyroid carcinoma.
Smit JW; Schröder-van der Elst JP; Karperien M; Que I; Romijn JA; van der Heide D
Exp Clin Endocrinol Diabetes; 2001; 109(1):52-5. PubMed ID: 11573141
[TBL] [Abstract][Full Text] [Related]
19. Visualization of endogenous p53-mediated transcription in vivo using sodium iodide symporter.
Kim KI; Chung JK; Kang JH; Lee YJ; Shin JH; Oh HJ; Jeong JM; Lee DS; Lee MC
Clin Cancer Res; 2005 Jan; 11(1):123-8. PubMed ID: 15671536
[TBL] [Abstract][Full Text] [Related]
20. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
Stein U; Walther W; Shoemaker RH
J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
